Dr. Albert Agro has served as the Chief Medical Officer of Cynapsus Therapeutics since August 2010. Since September 2008, Albert has also served as President and Chief Executive Officer of HNZ Strategic Holdings, Inc., a pharmaceutical and biotech consulting firm developing treatments for serious diseases. Prior to this role, Albert was Senior Vice President, Drug Development of TransTech Pharma, a pharmaceutical company, from September 2007 to December 2009. Albert completed his Ph.D. from the Department of Medicine at McMaster University. Albert has been an assistant professor, Department of Pathology and Molecular Medicine at McMaster University since September 1996. He is the recipient of a Michael J. Fox Foundation Clinical Scholarship for his work on Apomorphine.